Cargando…
KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma
BACKGROUND: Ovarian cancer (OV) is the highest prevalent gynecologic tumor with complicated pathogenesis; high-grade serous ovarian cystadenocarcinoma (HGSOC) is the most epidemiological and malignant subtype of OV. Keratin type I cytoskeleton 19 (KRT19) is an intermediate filament protein which pla...
Autores principales: | Sun, Zhe, Zhou, Ruijie, Dai, Jinjin, Chen, Jihua, Liu, Yu, Wang, Mengyi, Zhou, Runlong, Liu, Fengchen, Zhang, Qinxing, Xu, Yao, Zhang, Tongcun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616674/ https://www.ncbi.nlm.nih.gov/pubmed/37916194 http://dx.doi.org/10.2147/IJGM.S419235 |
Ejemplares similares
-
Gastric metastasis of ovarian serous cystadenocarcinoma
por: Yang, Shiqiang
Publicado: (2018) -
Serous cystadenocarcinoma of the spleen
por: Chou, Chung Kuao, et al.
Publicado: (2017) -
Gene Expression Subtyping Reveals Immune alterations:TCGA Database for Prognosis in Ovarian Serous Cystadenocarcinoma
por: Feng, Chunxia, et al.
Publicado: (2021) -
Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis
por: Liu, Hui, et al.
Publicado: (2020) -
A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma
por: Liu, Li-Wei, et al.
Publicado: (2016)